Abstract 459: Comprehensive molecular characterization of treatment naive muscle invasive bladder cancer

Autor: Ann Taber, Philippe Lamy, Iver Nodentoft, Emil Christensen, Frederik F. Prip, Sia V. Lindskrog, Karin Birkenkamp-Demtröder, Mads Agerbæk, Jørgen B. Jensen, Lars Dyrskjøt

Publikováno v: Cancer Research. 79:459-459

Background: The interplay between carcinoma cells and their microenvironment plays an important part in cancer development, progression, metastasis and treatment efficacy. In bladder cancer, however, little is currently known about how the tumor micr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a1f0ba42e788467b4dad5d44296968c4
https://doi.org/10.1158/1538-7445.am2019-459

Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.

Autor: Koutros S; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Electronic address: koutross@mail.nih.gov., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Pal Choudhury P; Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; American Cancer Society, Atlanta, GA, USA., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Lopez de Maturana E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain., Ye Y; Zhejiang University, Hangzhou, China., Joseph V; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Florez-Vargas O; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Dyrskjøt L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Figueroa J; Usher Institute, University of Edinburgh, Edinburgh, UK; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Dutta D; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Hildebrandt MAT; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Offit K; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kogevinas M; Instituto de Salud Global, Barcelona, Spain., Weiderpass E; International Agency for Research on Cancer, Lyon, France., McCullough ML; Population Science, American Cancer Society, Atlanta, GA, USA., Freedman ND; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Albanes D; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kooperberg C; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cortessis VK; Department of Population and Public Health Sciences, Epidemiology and Genetics, University of Southern California, Los Angeles, CA, USA., Karagas MR; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA., Johnson A; Vermont Department of Health, Burlington, VT, USA., Schwenn MR; Retired, Maine Cancer Registry, Augusta, ME, USA., Baris D; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Furberg H; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bajorin DF; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cussenot O; Centre de Recherche sur les Pathologies Prostatiques et Urologiques, Paris, France., Cancel-Tassin G; Centre de Recherche sur les Pathologies Prostatiques et Urologiques, Paris, France; GRC 5 Predictive Onco-Urology, Sorbonne University, Paris, France., Benhamou S; INSERM U1018, Research Centre on Epidemiology and Population Health, Villejuif, France., Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Porru S; Department of Diagnostics and Public Health, Section of Occupational Medicine, University of Verona, Verona, Italy., Carta A; Department of Diagnostics and Public Health, Section of Occupational Medicine, University of Verona, Verona, Italy., Bishop T; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia; Department of Clinical Pathology, The University of Melbourne, Parkville, Australia., Matullo G; Department of Medical Sciences, University of Turin, Turin, Italy., Fletcher T; London School of Hygiene and Tropical Medicine, London, UK., Kumar R; Division of Functional Genome Analysis, German Cancer Research Center, Heidelberg, Germany., Taylor JA; Epidemiology Branch and Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Kalisz M; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain., Weinstein SJ; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany., Selinski S; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany., Harland M; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Teo M; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Kiltie AE; Rowett Institute, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK., Tardón A; Department of Preventive Medicine, Universidad de Oviedo, ISPA and CIBERESP, Spain., Serra C; Center for Research in Occupational Health, Universitat Pompeu Fabra, Hospital del Mar Medical Research Institut, CIBERESP, Barcelona, Spain., Carrato A; Department of Medicine, Alcalá University, IRYCIS, CIBERONC, Madrid, Spain., García-Closas R; Hospital Universitario de Canarias, Tenerife, Spain., Lloreta J; Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain., Schned A; Department of Pathology, Dartmouth Medical School, Hanover, NH, USA., Lenz P; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Riboli E; School of Public Health, Imperial College London, London, UK., Brennan P; International Agency for Research on Cancer, Lyon, France., Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark., Otto T; Department of Urology, Rheinland Klinikum, Lukaskrankenhaus, Neuss, Germany., Ovsiannikov D; Department of Urology, St.-Josefs-Hospital, Dortmund, Germany., Volkert F; Department of Urology, Evangelic Hospital, Paul Gerhardt Foundation, Lutherstadt Wittenberg, Germany., Vermeulen SH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Aben KK; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Galesloot TE; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Turman C; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., De Vivo I; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Giovannucci E; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Hunter DJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Hohensee C; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hunt R; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Patel AV; Population Science, American Cancer Society, Atlanta, GA, USA., Huang WY; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Thorleifsson G; deCODE genetics/Amgen, Reykjavik, Iceland., Gago-Dominguez M; Fundación Pública Galega de Medicina Xenómica, Servicio Galego de Saude, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain., Amiano P; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastian, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Golka K; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany., Stern MC; Department of Population and Public Health Sciences, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Yan W; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Liu J; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Li SA; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Katta S; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hutchinson A; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hicks B; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wheeler WA; Information Management Services, Inc, Rockville, MD, USA., Purdue MP; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., McGlynn KA; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kitahara CM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Haiman CA; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Rafnar T; deCODE genetics/Amgen, Reykjavik, Iceland., Chatterjee N; Johns Hopkins University, Baltimore, MD, USA., Chanock SJ; Office of the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Wu X; Zhejiang University, Hangzhou, China., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain; Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain., Silverman DT; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Garcia-Closas M; Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Stefansson K; deCODE genetics/Amgen, Reykjavik, Iceland., Prokunina-Olsson L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO) and CIBERONC, Madrid, Spain., Rothman N; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Publikováno v: European urology [Eur Urol] 2023 Jul; Vol. 84 (1), pp. 127-137. Date of Electronic Publication: 2023 May 19.

Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer.

Autor: Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Christensen E; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Andreasen TG; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Kjær A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Ranti D; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Wang YA; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Bieber C; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Rasmussen J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Steiniche T; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Birkbak N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Sfakianos J; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Horowitz A; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Urology, Aarhus University Hospital, Aarhus, Denmark., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: lars@clin.au.dk.

Publikováno v: European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 646-656. Date of Electronic Publication: 2022 Oct 07.

Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer.

Autor: Taber A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Agerbæk M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Urology, Aarhus University Hospital, Aarhus, Denmark., Steiniche T; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: lars@clin.au.dk.

Publikováno v: European urology oncology [Eur Urol Oncol] 2022 Apr; Vol. 5 (2), pp. 203-213. Date of Electronic Publication: 2022 Feb 25.

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Autor: Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark., Taber A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Groeneveld CS; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France.; Oncologie Moleculaire, UMR144, Institut Curie, Paris, France., Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Urology, Aarhus University Hospital, Aarhus N, Denmark., Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark., Christensen E; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Sokac M; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Birkbak NJ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Maretty L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hermann GG; Department of Urology, Herlev hospital, Copenhagen University, Copenhagen, Denmark., Petersen AC; Department of Pathology, Aalborg University Hospital, Aalborg, Denmark., Weyerer V; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany., Horstmann M; Department of Urology, Jena University Hospital, Jena, Germany.; Department of Urology, Malteser Hospital St. Josephshospital, Krefeld Uerdingen, Krefeld, Germany., Sjödahl G; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Steiniche T; Department of Pathology, Aarhus University Hospital, Aarhus N, Denmark., Mogensen K; Department of Urology, Herlev hospital, Copenhagen University, Copenhagen, Denmark., de Reyniès A; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France., Nawroth R; Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany., Jordan B; Departments of Pathology, Urology, Biochemistry and Molecular Genetics, Northwestern University School of Medicine, Chicago, IL, USA., Lin X; Departments of Pathology, Urology, Biochemistry and Molecular Genetics, Northwestern University School of Medicine, Chicago, IL, USA., Dragicevic D; Clinic of Urology, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Ward DG; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK., Goel A; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK., Hurst CD; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Raman JD; Department of Surgery, Division of Urology, Pennsylvania State University, Hershey, PA, USA., Warrick JI; Department of Pathology and Laboratory Medicine, Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, Hershey, PA, USA., Segersten U; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Sikic D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., van Kessel KEM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Maurer T; Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.; Department of Urology and Martini-Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Meeks JJ; Departments of Pathology, Urology, Biochemistry and Molecular Genetics, Northwestern University School of Medicine, Chicago, IL, USA., DeGraff DJ; Department of Pathology and Laboratory Medicine, Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, Hershey, PA, USA., Bryan RT; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK., Knowles MA; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Simic T; Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Zwarthoff EC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Malmström PU; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), CIBERONC, Madrid, Spain., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, CIBERONC, Barcelona, Spain., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark. lars@clin.au.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. lars@clin.au.dk.

Publikováno v: Nature communications [Nat Commun] 2021 Apr 16; Vol. 12 (1), pp. 2301. Date of Electronic Publication: 2021 Apr 16.